Arkolith/Insider Trading/CMMB/Form 4

Mor George Adi

Chief Scientific Officer, DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jan 5, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$69K
Net Open-Market Flow
-$69K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2023Sell(S)6K$5.03$31K251K
Jan 3, 2023Sell(S)8K$5.03$39K317K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2018Grant(A)132K—$0132K
Oct 28, 2016Grant(A)34K—$034K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-23-000076) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML